Anne Grahl
InvestorAnalyst at Pureos Bioventures
Switzerland
Writes $100K – $5M checks · typically $1.5M
About
Anne Grahl is an Investment Manager at Pureos Bioventures with a background in biochemistry, structural biology, and biophysics. She works at the intersection of science and venture capital within the biotech sector.
Experience
- Pureos BioventuresInvestment Managercurrent2025 — present
- Pureos BioventuresAssociate2023 — 2025Switzerland
- Pureos BioventuresAnalyst2021 — 2023Switzerland
- PulseSight TherapeuticsBoard Membercurrent2025 — present
- Mediar TherapeuticsBoard Observercurrent2023 — present
- YVC CollectiveBoard Membercurrent2023 — present
- M VenturesInvestment Analyst2021Amsterdam Area
- i&i PragueCollaborator2020 — 2021
- Biozentrum, University of BaselPostdoctoral Researcher2019 — 2021
- Biozentrum, University of BaselPhD Student2014 — 2018
Education
- Biozentrum, University of BaselDoctor of Philosophy - PhD, Structural Biology2014 — 2018
- European Summer SchoolEntrepreneurship and New Venture Creation2020
- Kiel UniversityMaster of Science - MS, Biochemistry and Molecular Biology2011 — 2013
- University of YorkErasmus program, Biochemistry2010 — 2011
- Friedrich Schiller University JenaBachelor of Science - BS, Biochemistry and Molecular Biology2008 — 2011
Skills & more
Public SpeakingAnalytic Problem Solving1TeamworkInvestments1Project Leadership1Portfolio ManagementMembrane Proteins1BiophysicsBiochemistryScientific WritingTime Management1Molecular & Cellular Biology1
+5 more
ResearchProject ManagementComputational BiologyStructural BiologyCorporate Venture CapitalLanguages English · German
From Anne's professional profile.
Same school
Also attended Biozentrum, University of Basel1
Also attended University of York32
Bob ThomasPartner at OxxMarkInvestor at Boundary CapitalPhil VenablesVenture Partner at Ballistic VenturesAnthony AvedissianPartner at Canonical CryptoConor ScanlanAssociate Partner at Nauta CapitalRosanne WhalleyCEO at AHL Venture Partners
+ 26 more
Also attended Friedrich Schiller University Jena8
Clemens HabigImpact Consultant at GreenTec Capital PartnersYasmine ZiediJunior Analyst at GreenTec Capital PartnersAngela LawaldtManaging Partner at BONVENTUREHenri KühnertCo-Founder and Partner at b10Alena IvashenkaLife Sciences Investor at Venture Capital World SummitChristoph BrojaPartner at EQT Life Sciences
+ 2 more
Shared employers
Also worked at Pureos Bioventures10
Klaus BreinerManaging Partner at Pureos BioventuresDominik EscherManaging Partner at Pureos BioventuresMartin MünchbachManaging Partner at Pureos BioventuresXiming DingInvestment Manager at Pureos BioventuresButrint AliuAnalyst at Pureos BioventuresVeronica Gambillara FonckPartner at Pureos Bioventures
+ 4 more
Also worked at PulseSight Therapeutics1
Also worked at Mediar Therapeutics5
Colleagues at Pureos Bioventures
Butrint Aliu
Analyst at Pureos Bioventures
Christian Altorfer
CFO/COO at Pureos Bioventures
Dominik Escher
Managing Partner at Pureos Bioventures
Dragan Grabulovski
Venture Partner at Pureos Bioventures
Klaus Breiner
Managing Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Luigi Costa
Investor at Pureos Bioventures
Martin Münchbach
Managing Partner at Pureos Bioventures
Network5
Dominik Escher
Managing Partner at Pureos Bioventures
Dragan Grabulovski
Venture Partner at Pureos Bioventures
Klaus Breiner
Managing Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Luigi Costa
Investor at Pureos Bioventures
Investors connected to Anne in public investor directories — a warm-intro map.



























_edited_edited.jpg)




